SE8400688L - NEW PHARMACOLOGICALLY ACTIVE SOCIETIES - Google Patents

NEW PHARMACOLOGICALLY ACTIVE SOCIETIES

Info

Publication number
SE8400688L
SE8400688L SE8400688A SE8400688A SE8400688L SE 8400688 L SE8400688 L SE 8400688L SE 8400688 A SE8400688 A SE 8400688A SE 8400688 A SE8400688 A SE 8400688A SE 8400688 L SE8400688 L SE 8400688L
Authority
SE
Sweden
Prior art keywords
alkoxy
aryl
alkyl
alkylamino
opt
Prior art date
Application number
SE8400688A
Other languages
Swedish (sv)
Other versions
SE8400688D0 (en
Inventor
A E Brendstrom
S A I Carlsson
B I M Kellsson
P L Lindberg
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8300736A external-priority patent/SE8300736D0/en
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8400688A priority Critical patent/SE8400688L/en
Publication of SE8400688D0 publication Critical patent/SE8400688D0/en
Publication of SE8400688L publication Critical patent/SE8400688L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Cpds. of formula (I) and their salts when X is S are new:- X=S or -S(O)-; R15=H, CH3 or C2H5; R1, R2, R3, R4=same or different H, halo, CN, -CHO, CF3, -COR'', -CH(OR13)2, -(Z)n-A-D, aryl, aryloxy, 1-6C alkylthio, NO2, 1-6C alkylsulphinyl or adjacent gps. R1, R2, R3, R4 together form a 5,6 or 7 membered monocyclic ring or 9, 10 or 11 membered bicyclic Mg both opt. unsatd. and opt. contg. 0 to 3 of N and/or O fused to the benzimidazole ring. R11 and R12=same or different aryl, 1-4C alkoxy, 1-3C alkoxy (1-3C) alkoxy, aryl (1-2C) alkoxy, aryloxy, di(1-3C)alkylamino, pyrrolidino or piperidino both opt. substd. by 1-3C alkyl; R13=1-4C alkyl or 2-3C alkylene; Z=-O- or -C(=O)-; L=0 or 1; A=1-6C alkylene, 3-6C cycloalkylene, 2-6C alkylene, 3-6C cycloalkylene or 2-6C alkynylene; D=CN, -C(=O)R9, -(Y)m-(C=O)r-R16; R9=1-5C alkoxy or di(1-3C)alkylamino; m=O or 1; r=O or 1; y=-O-, -NH-, -NR10-; R10=H, 1-3C alkyl, aryl(1-2C) alkyl or aryl; R5=H or -CO-R14; R14=1-6C alkyl, aryl(1-2C) alkyl, aryl, 1-4C alkoxy, aryl(1-2C) alkyl, aryloxy, amino, mono- or di-(1-4C) alkylamino, aryl(1-2C) alkylamino or arylamino; R6 and R8=same or different H, or 1-5C alkyl; R7=1-8C alkyl, 1-8C alkoxy, 2-5C alkenyloxy, 2-5C alkynyloxy, 1-2C alkoxy (1-2C) alkoxy, di(1-2C) alkylamino (1-4C) alkoxy, 3-7C oxacycloalkyl, 4-7C oxacycloalkoxy, 4-7C oxacycloalkylalkyl, 4-6C oxacycloalkylalkoxy R6 and R7 or R7 and R8 together with the adjacent carbon atoms in the pyridine form a ring where R6 and R7 or R7 and R8 is -CH=CH-CH=CH-, -O-(CH2)p-, -CH2(CH2)p-, -O-CH=CH-, -NH-CH=CH- or -N(CH3)CH=CH- p=2,3 or 4.(0/0)
SE8400688A 1983-02-11 1984-02-09 NEW PHARMACOLOGICALLY ACTIVE SOCIETIES SE8400688L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE8400688A SE8400688L (en) 1983-02-11 1984-02-09 NEW PHARMACOLOGICALLY ACTIVE SOCIETIES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8300736A SE8300736D0 (en) 1983-02-11 1983-02-11 NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
SE8400688A SE8400688L (en) 1983-02-11 1984-02-09 NEW PHARMACOLOGICALLY ACTIVE SOCIETIES

Publications (2)

Publication Number Publication Date
SE8400688D0 SE8400688D0 (en) 1984-02-09
SE8400688L true SE8400688L (en) 1984-08-12

Family

ID=26658388

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400688A SE8400688L (en) 1983-02-11 1984-02-09 NEW PHARMACOLOGICALLY ACTIVE SOCIETIES

Country Status (1)

Country Link
SE (1) SE8400688L (en)

Also Published As

Publication number Publication date
SE8400688D0 (en) 1984-02-09

Similar Documents

Publication Publication Date Title
ES8601213A1 (en) Cephalosporin derivatives.
ES8609263A1 (en) 3-Amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use.
FI956237A0 (en) Process for the preparation of aromatic olefins
CA2147056A1 (en) Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
KR920006313A (en) Sulfonamide fibrinogen receptor antagonists
ES8404990A1 (en) Anti-hypertensive prolinol-based peptides.
ES2010071A6 (en) Isoquinoline derivatives and their use
ATE131484T1 (en) 3-TETRAZOLYLTHIOMETHYL CEPHALOSPORIN ANTIBIOTICS
DE3878235D1 (en) ANTISCHIZOPHREN EFFECTIVE S-N- (1-AZABICYCLO (2.2.2.) OCT-3-YL) BENZAMIDES AND THIOBENZAMIDES.
SE8400688L (en) NEW PHARMACOLOGICALLY ACTIVE SOCIETIES
DE3781174D1 (en) USE OF AROMATIC DIAMINES FOR THE TREATMENT OF ANGINA PECTORIS AND DIAMINE DAFUER.
ES8601963A1 (en) (1H-tetrazol-5-yl)-2(1H)-quinolinones.
IL91648A (en) Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
ES8601943A1 (en) Benzothiazine derivatives, processes for their preparation, medicaments containing them, and their use.
EP0233291A4 (en) 2-arylbenzothiazine derivatives.
SE8600742L (en) TREATMENT
IL81258A0 (en) Dihydropyridinelactols,their preparation and pharmaceutical compositions containing them
ES8604149A1 (en) 1,4-Dihydropyridines, method for their preparation and their use as medicaments.
FR2248050A1 (en) 4,5-dihydro-4h-s-triazolo (4,3-a) (1,4) benzodiazepine - cns depressants, anti-convulsants, anti-aggressives and somatic reflex in
SE8802997L (en) AMINERY DERIVATIVES AND ITS SALT, PROCEDURES FOR PREPARING THEREOF AND Means against their containing
ES8802320A1 (en) Pyridazo (1, 2-a)(1, 2) diazepine derivative
FR2194424A1 (en) Trialkoxybenzoylpeptide derivs - for treatment of cardiac disorders
ES8900272A1 (en) Pyridazo-(1,2-A)(1,2)-diazepine-1-carboxylic acid derivs.
PT82558A (en) Process for the preparation of morphinan derivatives
CO4700467A1 (en) DERIVATIVES OF CEPHALOSPORIN FLUOROQUINOLONATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8400688-1

Effective date: 19900917

Format of ref document f/p: F